AI Drug Discovery’s Validation Moment: The Scarcity Is Not Molecule Generation—It’s a Fully Connected R&D Loop

Within a week, AI drug discovery has seen a dense stream of financing, partnership, and policy signals, while China’s first AI-assisted new drug was approved for market. The industry is moving from model capability to output from the R&D system. But molecular generation speed does not equal drug development speed; the real threshold is connecting models, experiments, data, and clinical development into a closed loop—a systemic capability that StarWar Cloud tracks in AI computing power...